Business
Capital Reconstruction
Capital Reconstruction.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n Advanced Medical Solutions Grp PLC\n23 July 2007\n\n\nFor immediate release 23 July 2007\n\n\n\n Advanced Medical Solutions Group plc\n\n ('AMS' or 'the Company')\n\n Capital Reconstruction\n\n\n\n Reduction of the Company's share capital by the cancellation of its Deferred\n Shares of 5p each and the cancellation of the Company's share premium account\n\n\n\n\n\nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global\nmedical technology company today announces further progress in its Capital\nReconstruction that will enable it to pay a dividend in the future should the\nBoard make a recommendation to do so.\n\n\n\n\n\nFurther to the announcement of 6 June 2007, the Company announces that the High\nCourt of Justice confirmed the reduction of the Company's share capital by the\ncancellation of its Deferred Shares of 5p each and the cancellation of the\nCompany's share premium account on 4 July 2007. The reduction and cancellation\nbecame effective on 6 July 2007 on the registration by the Registrar of\nCompanies of the court order and of the minute approved by the court setting out\nthe particulars of the Company's share capital as altered by that order by\ncertificate given by the Registrar on 16 July 2007.\n\n -- ENDS --\n\n\n\nFor further information, please contact:\n\n\nAdvanced Medical Solutions Group plc +44 (0) 01606 545508\nDon Evans (Chief Executive Officer)\nMary Tavener (Group Finance Director)\nwww.admedsol.com\n\nBuchanan Communications +44 (0) 020 7466 5000\nMark Court/Mary-Jane Johnson\n\n\n\nNotes to Editors:\n\n\n\nAdvanced Medical Solutions is a UK based company developing and providing\nleading edge technology to the $15 billion global woundcare market.\n\nFounded in 1991 and quoted on AIM, the Company is focused on the design,\ndevelopment, manufacture and sale of advanced woundcare dressings and products\nfor closing wounds and sealing tissue.\n\nAMS provides a full range of advanced woundcare products for sale in hospital,\nnursing home and community care markets. The main indications are for chronic\nwounds such as ulcers and pressure sores. These products pioneer the concept of\nmoist wound healing to allow wounds to heal faster and with less pain and\nscarring if they remain moist. They protect the wound, deal with tissue fluids\nand provide an optimal environment for healing to occu...